Table 2

Univariate HRs for lymphoid malignancy and all malignancies (excluding lymphoid malignancy) among patients and controls
Total Patients with herpes zoster Matched-control subjects
Presence of lymphoid malignancy
Yes, no. (%) of patients 154 (0.07) 48 (0.11) 106 (0.06)
No, no. (%) of patients 212,105 (99.93) 42,348 (99.89) 169,757 (99.94)
Univariate HRa (95% CI) - 1.82 (1.29-2.55) Reference
P value 0.0006
Presence of cancer (excluded lymphoid malignancy)
Yes, no. (%) of patients 4,865 (2.29) 1,027 (2.42) 3,838 (2.26)
No, no. (%) of patients 207,590 (97.71) 41,458 (97.58) 166,132 (97.74)
Univariate HRa (95% CI) - 1.07 (1.01-1.15) Reference
P value 0.0465

aHR: Hazard ratio.

Liu et al.

Liu et al. BMC Cancer 2012 12:503   doi:10.1186/1471-2407-12-503

Open Data